The global creatinine measurement market size is anticipated to expand at a significant CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the high pervasiveness of renal disorders.
Creatinine is a naturally occurring byproduct of muscle metabolism. The clinical laboratory calculation of this waste product is used to determine glomerular filtration rate (GFR), which further determines patients' kidney activity. Jaffe's kinetic methods and enzymatic methods are two popular techniques used in the majority of routine creatinine assays currently in use. Creatinine measurement is primarily related to the identification and examination of rigorous renal disorders, which is mostly conducted using blood sample or urine sample of patients.
According to a data published by the American Kidney Fund, kidney diseases is the ninth leading cause of death in the US and chronic kidney disease gas affected more than 31 million people in the country alone. The presence of kidney disorders can be responsible for occurrence of several other chronic illness to a patient such as decreasing glomerular filtration rate has been linked to cardiovascular disease. One of the key aspects for the market expansion is the rapid growth of various technological advancement such as the introduction for the use of point-of-care creatinine measurement devices as a quick tool. The development has contributed to the elimination of the need for professional scientific professionals to carry out complex testing techniques.
Market Trends, Drivers, Restraints, and Opportunities
- High prevalence of rigorous renal disorders and rising cases of renal-related diseases are key drivers for the growing demand for creatinine measurement process. This is expected to boost the market.
- Growing development of health institutions as well as several government initiatives for the establishment of diagnostic clinics and hospitals are expected to propel the market expansion.
- Rapid development and production of innovative creatinine measurement kits and reagents from players to enhance the measurement techniques and methods are driving the market growth.
- Increasing number of the global geriatric population, who are more susceptible to renal diseases and favorable government policies to improve renal-based wellbeing present another key factors pushing the market.
- Changing healthcare professional tastes for novel approaches such as the detection of renal disease biomarkers and the lack of predictive utility achieved by creatinine calculation techniques, are key challenges likely to restrict the market expansion.
Scope of the Report
The report on the global creatinine measurement market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | Creatinine Measurement Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Types (Jaffe’s Kinetic Method and Enzymatic Method), Types of Sample (Blood/Serum and Urine), End-users (Hospitals, Diagnostic Laboratories, and Others), and Products (Reagents, and Kits) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | BioAssay Systems, Abcam plc, Arbor Assays, Thermo Fisher Scientific, Randox Laboratories Ltd., Sentinel CH. SpA, DiaSys Diagnostic Systems GmbH, MedTest Holdings, Inc. (Pointe Scientific, Inc.), Abbexa Ltd., and General Atomics, Inc. (Diazyme Laboratories, Inc.). |
Market Segment Insights
Jaffe’s Kinetic Method segment to constitute a substantial share
On the basis of types, the global creatinine measurement market is bifurcated into Jaffe’s kinetic method and enzymatic method. The Jaffe’s kinetic method segment is expected to constitute a substantial market share in the coming years owing to the wide deployment of the method for the measurement procedures.
Blood Sample segment to hold a large market share
Based on types of sample, the market is bifurcated into blood/serum and urine. The blood segment is anticipated to account for a large share of the creatinine measurement market during the forecast period due to its improved precision and low chance of infection. Moreover, the rising adoption of the sample as the most favored process for reliable creatinine calculation is another key aspect for the segment growth.
Hospitals segment to accounts for a major share
Based on the end-users, the creatinine calculation market is divided into hospitals, diagnostic laboratories, and others. The hospitals segment is projected to accounts for a key share of the market because of existing infrastructures with advanced diagnostic assemblies for improved diagnostic outcomes in shorter time periods. However, the diagnostic laboratories segment is anticipate to expand at a substantial CAGR during the forecast period owing to easy accessibility and rapid expansion of various private diagnostic clinics.
Kits segment is to exhibit a high CAGR
On the basis of products, the market is segregated into reagents and kits. The kits segment is projected to exhibit a considerable CAGR during the forecast period owing to rapid production of advanced and high-accurate measurement devices. Rising development of innovative technology and techniques for the deployment of kits is another key driving factor for the segment growth.
Asia Pacific market is expected to grow at a rapid pace
In terms of regions, the global creatinine measurement market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to factors such as increasing CKD prevalence, increased understanding of preventive healthcare, improved healthcare facilities, and a growing focus of market players on meeting demand in many Asian countries. Furthermore, as the existing markets become saturated, Asia is projected to become a key market destination for creatinine package and reagent providers in the coming years.
Segments
Segments Covered in the Report
The global creatinine measurement market has been segmented on the basis of
Types
- Jaffe’s kinetic method
- Enzymatic method
Types of Sample
End-users
- Hospitals
- Diagnostic Laboratories
- Others
Products
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- BioAssay Systems
- Abcam plc
- Arbor Assays
- Thermo Fisher Scientific
- Randox Laboratories Ltd.
- Sentinel CH. SpA
- DiaSys Diagnostic Systems GmbH
- MedTest Holdings, Inc.
Competitive Landscape
Some of the key players of the global creatinine measurement market are BioAssay Systems, Abcam plc, Arbor Assays, Thermo Fisher Scientific, Randox Laboratories Ltd., Sentinel CH. SpA, DiaSys Diagnostic Systems GmbH, and MedTest Holdings, Inc. These industry players are actively enagaged in developing advanced kits and reagents, as well as introducing innovative strategies for increasing their market positions.
Request For Customization
Enquiry Before Buying
Speak With Analyst
